Press Release Archive

August 24, 2021

EOM PHARMACEUTICALS ANNOUNCES FIRST PATIENTS DOSED IN R1: RESCUE PHASE 1/2A OPEN-LABEL TRIAL EVALUATING EOM613 IN HOSPITALIZED COVID-19 PATIENTS WITH SEVERE SYMPTOMS IN BRAZIL

DOWNLOAD

July 22, 2021

EOM PHARMACEUTICALS APPOINTS DRUG DEVELOPMENT VETERAN FRANK L. DOUGLAS, Ph.D., M.D., SCIENTIFIC ADVISOR

DOWNLOAD

December 24, 2020

EOM PHARMACEUTICALS ANNOUNCES ITS PRE-IND MEETING REQUEST WITH U.S. FDA TO EVALUATE PLANS FOR A PHASE 2 CLINICAL TRIAL OF ITS INVESTIGATIONAL DUAL-ACTING, BROAD-SPECTRUM IMMUNOMODULATOR IN COVID-19 PATIENTS

DOWNLOAD

December 17, 2020

EOM PHARMACEUTICALS APPOINTS BUSINESS VETERAN WAYNE I. DANSON AS CHIEF FINANCIAL OFFICER AND TREASURER

DOWNLOAD